Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity

Cancer

Volumn 119, Issue 15, 2013, Pages 2807-2814

  Solanki, Abhishek A ^a   Liauw, Stanley L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

prostate cancer; radiotherapy; smoking; tobacco; toxicity

Indexed keywords

TOBACCO SMOKE;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; CANCER CONTROL; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FREEDOM FROM BIOCHEMICAL FAILURE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SMOKING; TOXICITY; UNIVARIATE ANALYSIS; UROGENITAL TRACT TOXICITY;

PROSTATE CANCER; RADIOTHERAPY; SMOKING; TOBACCO; TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION INJURIES; SMOKING; TREATMENT OUTCOME; UNITED STATES;

EID: 84880572476     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28128     Document Type: Article

References (23)

1. Hamilton AS, Albertsen PC, Johnson TK, et al. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011; 107: 576-584.
2. Vital signs: current cigarette smoking among adults aged >/=18 years-United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1207-1212.
3. Sagone AL Jr, Lawrence T, Balcerzak SP,. Effect of smoking on tissue oxygen supply. Blood. 1973; 41: 845-851.
4. Fox JL, Rosenzweig KE, Ostroff JS,. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer. 2004; 44: 287-293.
5. Kucera H, Enzelsberger H, Eppel W, Weghaupt K,. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer. 1987; 60: 1-4.
6. Chen AM, Chen LM, Vaughan A, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011; 79: 414-419.
7. Goldstein I, Feldman MI, Deckers PJ, Babayan RK, Krane RJ,. Radiation-associated impotence. A clinical study of its mechanism. JAMA. 1984; 251: 903-910.
8. Peeters ST, Heemsbergen WD, van Putten WL, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005; 61: 1019-1034.
9. Alsadius D, Hedelin M, Johansson KA, et al. Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol. 2011; 101: 495-501.
10. Pantarotto J, Malone S, Dahrouge S, Gallant V, Eapen L,. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int. 2007; 99: 564-569.
11. Pickles T, Liu M, Berthelet E, Kim-Sing C, Kwan W, Tyldesley S,. The effect of smoking on outcome following external radiation for localized prostate cancer. J Urol. 2004; 171: 1543-1546.
12. Edge SB, Compton CC,. The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474.
13. Szymanski KM, Wei JT, Dunn RL, Sanda MG,. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010; 76: 1245-1250.
14. Roach M 3rd, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006; 65: 965-974.
15. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 1341-1346.
16. Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL,. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys. 2012; 82: 235-241.
17. Zu K, Giovannucci E,. Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control. 2009; 20: 1799-1810.
18. Oh JJ, Hong SK, Jeong CW, Byun SS, Lee SE,. Significance of smoking status regarding outcomes after radical prostatectomy. Int Urol Nephrol. 2012; 44: 119-124.
19. Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E,. Smoking and prostate cancer survival and recurrence. JAMA. 2011; 305: 2548-2555.
20. Azadzoi KM, Shinde VM, Tarcan T, Kozlowski R, Siroky MB,. Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder. J Urol. 2003; 169: 1885-1891.
21. Hisayama T, Shinkai M, Takayanagi I, Toyoda T,. Mechanism of action of nicotine in isolated urinary bladder of guinea-pig. Br J Pharmacol. 1988; 95: 465-472.
22. Nuotio M, Jylha M, Koivisto AM, Tammela TL,. Association of smoking with urgency in older people. Eur Urol. 2001; 40: 206-212.
23. Bump RC, McClish DK,. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol. 1992; 167: 1213-1218.